Sections
- What is Flexion Therapeutics (NASDAQ:FLXN) and Zilretta?
- Why is Zilretta Better?
- Safety and JAMA Article
- The Osteoarthritis Market
- Risk to Reward
- Financials
- Summary
What is Flexion Therapeutics?
Pronounced Flex-shun, the company is based around a slow-release formulation and delivery platform. Currently, it is nearly 100% focused on its lead candidate Zilretta, but its technology is adaptable to many site-specific, slow-release formulations. The fundamental technology behind Flexion is its "microsphere" technology, or small beads which house active drugs.
